FIELD: medicine.
SUBSTANCE: one should apply hydrosulfate carbon-mercury complex (HCMC) containing below 50 mcg mercury in 0.05 ml preparation and, also, selenic phospholipoglycoprotein substance (SPLGPS) and/or selenic carotinoprotein substance (SCPS) of immunocorrecting and immunomodulating actions. Moreover, during 3 mo HCMC should be introduced perorally at the dosage of 0.05 ml preparation for 1-2 d, and selenic-protein substances should be introduced parenterally at daily dosage of 0.2-0.4 ml/2-10 ml physiological solution. The method provides complex impact onto body immune system by restoring and activating immunoreceptors and, also, onto retroviruses by causing their destruction or suppression of their activity.
EFFECT: higher efficiency of therapy.
8 cl, 9 dwg, 2 ex, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING CHRONIC DISEASES OF EAR-NOSE-THROAT ORGANS WITH VIRAL, BACTERIAL, AND MIXED VIRAL-BACTERIAL ETIOLOGY IN HIV-INFECTED CHILDREN AND ADOLESCENTS | 2004 |
|
RU2305558C2 |
NANOMOLECULAR SELENIUM-TERPENE-PROTEIN AGENT AND METHOD FOR TREATMENT OF PATIENTS WITH DEPENDENCE FROM PSYCHOACTIVE SUBSTANCES | 2003 |
|
RU2242235C1 |
CHELATED MERCURY COMPLEXES WITH CYSTEINE AND METHIONINE, METHOD FOR PREPARING THEM, AND DRUG PREPARATION MERCURID APOPTOSIS MODULATOR SHOWING ANTICANCER, ANTIVIRAL, ANTIPARASITIC AND IMMUNOMODULATING ACTION | 2010 |
|
RU2456001C2 |
METHOD OF DIAGNOSING EARLY MANIFEST CONGENITAL SYPHILIS | 2009 |
|
RU2402775C1 |
AGENT CARBON-MERCURY HYDROSULFATE COMPLEX AND METHOD OF TREATMENT OF INFECTIOUS INFLAMMATORY SICKNESSES | 2002 |
|
RU2196590C1 |
HIV-POSITIVE PATIENTS TREATMENT MODE | 2007 |
|
RU2360694C1 |
DIAGNOSTIC TECHNIQUE FOR HEPATIC CIRRHOSIS (STAGE F4) IN THE OUTCOME OF CHRONIC VIRAL HEPATITIS C | 2019 |
|
RU2724595C1 |
METHOD OF PREDICTING COMPLICATIONS AFTER COVID-19 IN PERSONS WITH COMORBID BACKGROUND IN THE ARCTIC REGION | 2023 |
|
RU2812780C1 |
IMMUNOCORRECTING AGENT AND METHOD OF IMMUNOCORRECTION | 1999 |
|
RU2138271C1 |
METHOD OF PREDICTING PROGRESSION OF HIV INFECTION IN PATIENTS RECEIVING ANTIRETROVIRAL THERAPY | 2019 |
|
RU2697392C1 |
Authors
Dates
2004-10-10—Published
2003-07-02—Filed